The rapidly expanding therapeutic role of thymosin α-1 in the management of gastrointestinal and systemic infectious disorders

Journal of Intensive Care Medicine

Volumn 24, Issue 3, 2009, Pages 210-211

  Kapoor, Shailendra ^a  

^a NONE

Author keywords

Chronic hepatitis C; Cytomegalovirus; Hepatosteatosis; Severe acute pancreatitis; Thymosin 1

Indexed keywords

THYMOSIN ALPHA1;

CELL DIFFERENTIATION; COLORECTAL CARCINOMA; DIETARY INTAKE; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; GASTROINTESTINAL DISEASE; HEPATITIS C; HUMAN; INFECTION; LETTER; PANCREATITIS; PRIORITY JOURNAL; T LYMPHOCYTE;

GASTROINTESTINAL DISEASES; HUMANS; INFECTION; THYMOSIN;

EID: 65949083122     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066609333445     Document Type: Letter

References (7)

1. Yumin L., Hao C., Xun L., et al. A new immunomodulatory therapy for severe sepsis: ulinastatin plus thymosin a 1. J Intensive Care Med. 2009 ; 24: 47-53.
2. Andreone P., Gramenzi A., Cursaro C., et al. Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial. J Viral Hepat. 2004 ; 11: 69-73. (Pubitemid 38221620)
3. Bozza S., Gaziano R., Bonifazi P., et al. Thymosin alpha1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo. Int Immunol. 2007 ; 19: 1261-1270. (Pubitemid 47604727)
4. Armutcu F., Coskun O., G1/4rel A., et al. Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats. Clin Biochem. 2005 ; 38: 540-547. (Pubitemid 40693468)
5. Ma LN, Chen XY, Chen J., Huang YL, Shen CL A clinical study of thymosin alpha1 as an auxiliary in treating spontaneous peritonitis in patients with liver cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2007 ; 15: 225.
6. Yao W., Zhu Q., Yuan Y., Qiao M., Zhang Y., Zhai Z. Thymosin alpha 1 improves severe acute pancreatitis in rats via regulation of peripheral T cell number and cytokine serum level. J Gastroenterol Hepatol. 2007 ; 22: 1866-1871. (Pubitemid 47525068)
7. Rasi G., Silecchia G., Sinibaldi-Vallebona P., et al. Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats. Int J Cancer. 1994 ; 57: 701-705. (Pubitemid 24201363)